Coagulation activation in extracorporeal hemodialysis

Area of Science:

• Nephrology
• Hematology
• Clinical Chemistry

Background:

• Patients with end-stage renal disease on maintenance hemodialysis often exhibit dysregulation of coagulation factors and lipoproteins.
• Protein C activity, coagulation factors VII and X, and serum lipoprotein(a) are critical in hemostasis and cardiovascular risk.
• Understanding their behavior during dialysis is crucial for managing complications in these patients.

Purpose of the Study:

• To investigate the impact of maintenance hemodialysis on protein C activity, factors VII and X coagulant activity, and serum lipoprotein(a) levels.
• To explore the in vitro effects of heparin on serum lipoprotein(a) in uremic and healthy blood.

Main Methods:

• Prospective evaluation of coagulation parameters and serum lipoprotein(a) in patients undergoing maintenance hemodialysis before and immediately after treatment.
• In vitro incubation experiments using uremic and healthy blood with and without heparin addition.

Main Results:

• Hemodialysis significantly increased depressed protein C activity to normal levels (p < 0.005).
• Coagulation factors VII and X showed significant increases (p < 0.01; p < 0.05) post-hemodialysis.
• Serum lipoprotein(a) levels increased post-hemodialysis, and in vitro, heparin specifically elevated lipoprotein(a) in uremic blood.

Conclusions:

• Maintenance hemodialysis effectively corrects depressed protein C activity and influences other coagulation factors.
• Heparin's role in modulating serum lipoprotein(a) in uremic patients warrants further investigation.
• These findings have implications for understanding thrombotic and cardiovascular risks in hemodialysis patients.